Latest News about JNJ
Recent news which mentions JNJ
3 Dividend Aristocrats to Buy and Hold Forever
Today 6:17 EST
From Motley Fool
Here's How Much Investing $1,000 In Major Coronavirus Vaccine Developers Before Their Announcements Would Fetch
November 27, 2020
From Benzinga
I’ve already been injected with a COVID vaccine. This is why I’m cheering for the Novavax underdog
November 26, 2020
From MarketWatch
Why Moderna Is Less Risky Than You Think
November 26, 2020
From Motley Fool
3 Index Funds Perfect for Your IRA
November 26, 2020
From Motley Fool
3 Stocks to Help You Build Retirement Wealth
November 25, 2020
From Motley Fool
Moderna Set to Sell 160 Million Coronavirus Vaccine Doses to EU
November 24, 2020
From Motley Fool
December Outlook: Holidays Arrive For A Wild 2020 As Volatility Eases, Vaccine Hopes Grow
November 24, 2020
From Benzinga
EU strikes deal with Moderna to supply up to 160 million vaccine shots
November 24, 2020
From MarketWatch
From Motley Fool
Moderna Hopes To Roll Out COVID-19 Vaccine For Children By Mid-Next Year
November 24, 2020
From Benzinga
Dr. Fauci on Cuomo’s decision to review vaccines for New Yorkers: ‘Trust the process because it is a sound process’
November 24, 2020
From MarketWatch
AstraZeneca’s COVID-19 vaccine data fails to impress Wall Street analysts with its effectiveness in clinical trials
November 23, 2020
From MarketWatch
3 Dividend Stocks to Buy on Sale
November 23, 2020
From Motley Fool
3 Top Value Stocks To Buy Right Now
November 23, 2020
From Motley Fool
2 Pick-and-Shovel COVID Vaccine Stocks to Watch
November 23, 2020
From Motley Fool
Bill Gates Says AstraZeneca, Johnson & Johnson, Novavax COVID-19 Vaccines All Likely To Prove 'Very Efficacious And Safe' By February
November 23, 2020
From Benzinga
Top COVID Vaccine Stocks to Buy Now
November 22, 2020
From Motley Fool
Why Do Baby Boomers Love AT&T?
November 22, 2020
From Motley Fool
A Coronavirus Vaccine Is Good News. What's Going on With Cruise Lines?
November 21, 2020
From Motley Fool
Is There Room for Latecomers to the COVID-19 Party?
November 21, 2020
From Motley Fool
Where Will Vaxart Be in 1 Year?
November 21, 2020
From Motley Fool
Pharma Sector Did Its Job With COVID-19 Vaccine: Barclays Analyst
November 20, 2020
From Benzinga
Pfizer and partner BioNTech to seek emergency-use authorization for COVID-19 vaccine Friday
November 20, 2020
From MarketWatch
Is Sorrento Therapeutics Stock a Buy?
November 20, 2020
From Motley Fool
Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna
November 20, 2020
From Motley Fool
Tale Of Two Earnings: Nvidia Results Solid All the Way Through, But Macy's Struggles
November 19, 2020
From Benzinga
3 ETFs Perfect for Robinhood Investors
November 19, 2020
From Motley Fool
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.